288 related articles for article (PubMed ID: 38674166)
21. Multi-Organs-on-Chips: Towards Long-Term Biomedical Investigations.
Zhao Y; Kankala RK; Wang SB; Chen AZ
Molecules; 2019 Feb; 24(4):. PubMed ID: 30769788
[TBL] [Abstract][Full Text] [Related]
22. Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine.
El Harane S; Zidi B; El Harane N; Krause KH; Matthes T; Preynat-Seauve O
Cells; 2023 Mar; 12(7):. PubMed ID: 37048073
[TBL] [Abstract][Full Text] [Related]
23. 3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration.
Wang H; Brown PC; Chow ECY; Ewart L; Ferguson SS; Fitzpatrick S; Freedman BS; Guo GL; Hedrich W; Heyward S; Hickman J; Isoherranen N; Li AP; Liu Q; Mumenthaler SM; Polli J; Proctor WR; Ribeiro A; Wang JY; Wange RL; Huang SM
Clin Transl Sci; 2021 Sep; 14(5):1659-1680. PubMed ID: 33982436
[TBL] [Abstract][Full Text] [Related]
24. A Modular Microfluidic Organoid Platform Using LEGO-Like Bricks.
Carvalho DJ; Kip AM; Tegel A; Stich M; Krause C; Romitti M; Branca C; Verhoeven B; Costagliola S; Moroni L; Giselbrecht S
Adv Healthc Mater; 2024 May; 13(13):e2303444. PubMed ID: 38247306
[TBL] [Abstract][Full Text] [Related]
25. 3D Hanging Drop Culture to Establish Prostate Cancer Organoids.
Eder T; Eder IE
Methods Mol Biol; 2017; 1612():167-175. PubMed ID: 28634942
[TBL] [Abstract][Full Text] [Related]
26. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
[TBL] [Abstract][Full Text] [Related]
27. Patient-derived explants, xenografts and organoids: 3-dimensional patient-relevant pre-clinical models in endometrial cancer.
Collins A; Miles GJ; Wood J; MacFarlane M; Pritchard C; Moss E
Gynecol Oncol; 2020 Jan; 156(1):251-259. PubMed ID: 31767187
[TBL] [Abstract][Full Text] [Related]
28. 3D Tumor Models and Their Use for the Testing of Immunotherapies.
Boucherit N; Gorvel L; Olive D
Front Immunol; 2020; 11():603640. PubMed ID: 33362787
[TBL] [Abstract][Full Text] [Related]
29. Advances in the use of 3D colorectal cancer models for novel drug discovery.
Baião A; Dias S; Soares AF; Pereira CL; Oliveira C; Sarmento B
Expert Opin Drug Discov; 2022 Jun; 17(6):569-580. PubMed ID: 35343351
[TBL] [Abstract][Full Text] [Related]
30. Tumor-on-a-chip models combined with mini-tissues or organoids for engineering tumor tissues.
Hwangbo H; Chae S; Kim W; Jo S; Kim GH
Theranostics; 2024; 14(1):33-55. PubMed ID: 38164155
[TBL] [Abstract][Full Text] [Related]
31. Cell Viability Assays in Three-Dimensional Hydrogels: A Comparative Study of Accuracy.
Dominijanni AJ; Devarasetty M; Forsythe SD; Votanopoulos KI; Soker S
Tissue Eng Part C Methods; 2021 Jul; 27(7):401-410. PubMed ID: 34082602
[TBL] [Abstract][Full Text] [Related]
32. Advanced biomedical applications based on emerging 3D cell culturing platforms.
Wang A; Madden LA; Paunov VN
J Mater Chem B; 2020 Dec; 8(46):10487-10501. PubMed ID: 33136103
[TBL] [Abstract][Full Text] [Related]
33. Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 2: Spheroids, Organoids, and Disease Modeling.
Eglen RM; Reisine T
SLAS Technol; 2019 Feb; 24(1):18-27. PubMed ID: 30798678
[TBL] [Abstract][Full Text] [Related]
34. Comparison of VEGF-A secretion from tumor cells under cellular stresses in conventional monolayer culture and microfluidic three-dimensional spheroid models.
Sarkar S; Peng CC; Tung YC
PLoS One; 2020; 15(11):e0240833. PubMed ID: 33175874
[TBL] [Abstract][Full Text] [Related]
35. Different Expression of Thyroid-Specific Proteins in Thyroid Cancer Cells between 2-Dimensional (2D) and 3-Dimensional (3D) Culture Environment.
Oh JM; Gangadaran P; Rajendran RL; Hong CM; Lee J; Ahn BC
Cells; 2022 Nov; 11(22):. PubMed ID: 36428988
[TBL] [Abstract][Full Text] [Related]
36. Using Biosensors to Study Organoids, Spheroids and Organs-on-a-Chip: A Mechanobiology Perspective.
Yousafzai MS; Hammer JA
Biosensors (Basel); 2023 Sep; 13(10):. PubMed ID: 37887098
[TBL] [Abstract][Full Text] [Related]
37. Historical evolution of spheroids and organoids, and possibilities of use in life sciences and medicine.
Sakalem ME; De Sibio MT; da Costa FADS; de Oliveira M
Biotechnol J; 2021 May; 16(5):e2000463. PubMed ID: 33491924
[TBL] [Abstract][Full Text] [Related]
38. 3D Models for Ovarian Cancer.
Kast V; Loessner D
Adv Exp Med Biol; 2021; 1330():139-149. PubMed ID: 34339035
[TBL] [Abstract][Full Text] [Related]
39. Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin.
Fallahi P; Ferrari SM; Elia G; Ragusa F; Patrizio A; Paparo SR; Marone G; Galdiero MR; Guglielmi G; Foddis R; Cristaudo A; Antonelli A
Semin Cancer Biol; 2022 Feb; 79():203-216. PubMed ID: 32569821
[TBL] [Abstract][Full Text] [Related]
40. Organoids/organs-on-a-chip: new frontiers of intestinal pathophysiological models.
Wu L; Ai Y; Xie R; Xiong J; Wang Y; Liang Q
Lab Chip; 2023 Mar; 23(5):1192-1212. PubMed ID: 36644984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
